4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-21-118360
SVP, Chief Scientific Officer sold 25,000 shares at $4.97 ($124,250)
- SVP, Chief Scientific Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/tm2127534-3_4seq1.xml…